We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$705K
AUM Growth
+$155K
Cap. Flow
+$37M
Cap. Flow %
5,239.6%
Top 10 Hldgs %
38.06%
Holding
169
New
34
Increased
12
Reduced
6
Closed
15

Sector Composition

Rank Sector Weight
1 Financials 20.77%
2 Technology 6.48%
3 Communication Services 3.35%
4 Industrials 2.86%
5 Healthcare 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPB.WS
126
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
-125,000
Closed -$58
VG
127
DELISTED
Vonage Holdings Corporation
VG
-532,244
Closed -$9.97K
VG
128
PUT
DELISTED
Vonage Holdings Corporation
VG
-4,394
Closed -$692
HR
129
DELISTED
Healthcare Realty Trust Incorporated
HR
-67,730
Closed -$1.87K

Similar funds

Boussard & Gavaudan Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Boussard & Gavaudan Investment Management held 169 positions worth $705K, up 28% from $551K the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Boussard & Gavaudan Investment Management deployed $37M of net new capital in Q3 2022, opening 34 new positions and adding to 12 existing holdings. Its largest new stake was CONTINENTAL RESOURCES INC.: 203,108 shares worth $13.6K.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Enovis, an estimated $3.6M trimmed.

  • Boussard & Gavaudan Investment Management's largest Q3 2022 buy was CONTINENTAL RESOURCES INC.: 203,108 shares worth $13.6K.
  • Boussard & Gavaudan Investment Management added most to Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares in Q3 2022, an estimated $7.35M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2022 reduction was Enovis, cutting an estimated $3.6M.
  • Boussard & Gavaudan Investment Management fully exited Change Healthcare Inc. Common Stock in Q3 2022, selling an estimated $15.7K.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 38% of its $705K portfolio in Q3 2022.
  • Boussard & Gavaudan Investment Management opened 34 new positions and closed 15 in Q3 2022.
  • Boussard & Gavaudan Investment Management's portfolio value rose 28% quarter-over-quarter to $705K.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.